General Information of the Compound
| Compound ID |
CP0426887
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(1S,2R,3S,4R)-4-[6-(2,2-diphenylethylamino)-2-[2-(1-propan-2-ylimidazol-4-yl)ethylamino]purin-9-yl]-2,3-dihydroxycyclopentyl]butanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C36H45N9O3
|
||||||||||||||||||
| Molecular Weight |
651.816
|
||||||||||||||||||
| Canonical SMILES |
CCCC(=O)N[C@H]1C[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NCC(c3ccccc3)c3ccccc3)nc(NCCc3cn(cn3)C(C)C)nc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C36H45N9O3/c1-4-11-30(46)41-28-18-29(33(48)32(28)47)45-22-40-31-34(38-19-27(24-12-7-5-8-13-24)25-14-9-6-10-15-25)42-36(43-35(31)45)37-17-16-26-20-44(21-39-26)23(2)3/h5-10,12-15,20-23,27-29,32-33,47-48H,4,11,16-19H2,1-3H3,(H,41,46)(H2,37,38,42,43)/t28-,29+,32+,33-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
CIMXZVURQFXWNX-MLVZTVGHSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound